Bank of Stockton Buys 69 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bank of Stockton boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.9% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,230 shares of the medical equipment provider’s stock after purchasing an additional 69 shares during the quarter. Bank of Stockton’s holdings in Intuitive Surgical were worth $609,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Atala Financial Inc acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $25,000. Parvin Asset Management LLC bought a new position in shares of Intuitive Surgical in the 4th quarter valued at $26,000. Global Financial Private Client LLC raised its holdings in shares of Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock worth $26,000 after buying an additional 38 shares in the last quarter. BankPlus Trust Department bought a new stake in shares of Intuitive Surgical during the 4th quarter worth $28,000. Finally, Hurley Capital LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter worth $28,000. Institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other news, Director Jami K. Nachtsheim sold 2,400 shares of the company’s stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the transaction, the director now directly owns 6,371 shares of the company’s stock, valued at $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Gary Loeb sold 1,700 shares of Intuitive Surgical stock in a transaction on Friday, April 25th. The stock was sold at an average price of $513.18, for a total value of $872,406.00. Following the sale, the executive vice president now owns 2,245 shares in the company, valued at $1,152,089.10. This trade represents a 43.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 4,998 shares of company stock valued at $2,611,577. 0.70% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research analysts have commented on the company. Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a “hold” rating to a “sell” rating and lowered their target price for the stock from $515.00 to $440.00 in a research note on Monday, June 9th. Citigroup reiterated a “buy” rating and set a $650.00 price objective (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the company a “buy” rating in a research report on Monday, April 14th. Truist Financial lowered their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a report on Wednesday, April 23rd. Finally, Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Thursday, June 5th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $588.95.

Intuitive Surgical Trading Down 0.3%

Shares of NASDAQ ISRG opened at $521.63 on Thursday. The firm’s 50-day moving average price is $530.03 and its 200-day moving average price is $536.86. The firm has a market capitalization of $186.96 billion, a P/E ratio of 76.49, a P/E/G ratio of 5.55 and a beta of 1.67. Intuitive Surgical, Inc. has a 1-year low of $413.82 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The business had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the previous year, the business posted $1.50 EPS. Equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.